|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/745 | |
| A61K 38/36 | |||
| A61P 7/04 |
| (11) | Patento numeris | 2147096 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08742852.0 |
| Europos patento paraiškos padavimo data | 2008-04-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-01-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-03-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/004795 |
| Data | 2008-04-11 |
| (87) | Numeris | WO 2008/127702 |
| Data | 2008-10-23 |
| (30) | Numeris | Data | Šalis |
| 923512 P | 2007-04-13 | US |
| (72) |
MADISON, Edwin, L., US
THANOS, Christopher, D., US
RUGGLES, Sandra, Waugh, US
COUGHLIN, Shaun, US
|
| (73) |
Catalyst Biosciences, Inc.,
260 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (54) | Modified factor VII polypeptides and uses thereof |
| Modified factor VII polypeptides and uses thereof |